Sodium Sulfite vs Carrageenan: which is worse?

What is Sodium Sulfite?

Sodium sulfite is an inorganic sulfite salt used as a food preservative and antioxidant. It releases sulfur dioxide when it contacts water or acid, which acts as the active antimicrobial and antioxidant agent. Part of the broader sulfite family of food additives (including sulfur dioxide E220, sodium bisulfite E222, and others).

What is Carrageenan?

Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.

Documented risks

Sodium Sulfite: Sulfites are among the more significant food allergy/intolerance triggers. An estimated 1 in 100 people, and up to 5% of asthmatics, are sulfite-sensitive. Reactions can include urticaria, angioedema, bronchospasm, and in severe cases anaphylaxis. Sulfite-induced asthma can be severe; several deaths attributable to sulfite-triggered anaphylaxis have been documented. The FDA banned sulfites from fresh produce and restaurant salad bars in 1986 after several deaths and severe reactions were linked to sulfite-treated salads. FDA mandates that sulfite content above 10 ppm be declared on US food labels. All forms of sulfites (E220-E228) share these sensitization concerns.

Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.